AlphaCentric Advisors LLC purchased a new position in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Free Report) during the first quarter, HoldingsChannel reports. The institutional investor purchased 7,500 shares of the company’s stock, valued at approximately $220,000. A number of other large investors also recently made changes to their positions in AMLX. Vanguard Group Inc. […]
Amylyx Pharmaceuticals (NASDAQ:AMLX – Get Free Report) and NRx Pharmaceuticals (NASDAQ:NRXP – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation and risk. Volatility & Risk Amylyx Pharmaceuticals has a […]
Shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Free Report) have received an average recommendation of “Buy” from the six ratings firms that are covering the stock, Marketbeat reports. Six equities research analysts have rated the stock with a buy rating. The average 12-month price target among analysts that have covered the stock in the […]
Emerald Mutual Fund Advisers Trust increased its stake in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Free Report) by 20.5% in the first quarter, HoldingsChannel.com reports. The firm owned 789,591 shares of the company’s stock after buying an additional 134,576 shares during the period. Amylyx Pharmaceuticals accounts for approximately 1.4% of Emerald Mutual Fund Advisers […]